ACHE and early-onset autosomal dominant Alzheimer disease: Current research indicates that increasing brain cholinergic neurotransmission by decreasing the chemical reaction to AChE hydrolysis is the most effective therapy for Alzheimer’s disease, although the pathophysiology of the illness is not entirely understood.